About UCB in the United States

At UCB, our purpose is to create value for patients now and in the future. We fulfill this purpose by elevating the lives of patient and their families through our medicines, creating positive change across society. We incorporate the individual experiences of patients and caregivers into the discovery, development, and delivery of our medicines, leveraging their insights to inform our science and develop innovative and differentiated solutions. This includes our commitment to collaborating with others in the healthcare system, our inclusive approach to research, and equitable access and affordability.

With a strong foundation in improving the lives of people with neurological and immunological conditions, we blend decades of scientific innovation with insights from patients and caregivers to create tailored solutions, including for rare conditions, that deliver meaningful impact. Our commitment to sustainable value creation drives our focus on inclusive research, equitable access to medicines, and advancements that benefit patients and society. Guided by our ESG principles, we strive to advance science, promote health equity, reduce our environmental footprint, and optimize shareholder value, fostering positive and lasting change.

Map

From our U.S. headquarters in Atlanta, Georgia, to our global home in Belgium, UCB's approximately 8,600 employees are focused on delivering moments that matter for people living with severe diseases, now and into the future. In the U.S., our footprint spans from coast to coast, with U.S. sites focused on global clinical development in Raleigh, North Carolina; on policy in Washington, D.C.; and research supporting UCB's pipeline in Boston, Massachusetts and Seattle, Washington as well as Durham, North Carolina.

Our Atlanta headquarters focuses on the delivery of our innovative therapies, ensuring patients, caregivers, and their healthcare providers are supported and can access our solutions.